Stockreport

MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations [Seeking Alpha]

MannKind Corporation  (MNKD) 
Last mannkind corporation earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.mannkindcorp.com/press-releases
PDF CEO Michael Castagna emphasized the transformation of MannKind, stating, "Tyvaso DPI has transformed both United Therapeutics and MannKind's future to fund our respecti [Read more]